All sites C00-96,D32-33,D42-43,D45-47,D76 323 87.9 2.7 3.5 0.2 5.7
Mouth, pharynx C00-14 3 88.2 - - - 11.8
  Lip C00 0 100.0 - - - -
  Tongue C02 1 80.0 - - - 20.0
  Mouth, other C03-06 2 88.9 - - - 11.1
  Salivary glands C07-08 0 100.0 - - - -
  Pharynx C01,C09-14 - - - - - -
Digestive organs C15-26 69 81.0 0.6 6.9 0.3 11.2
  Oesophagus C15 1 71.4 - - - 28.6
  Stomach C16 9 97.9 - - - 2.1
  Small intestine C17 1 83.3 - - - 16.7
  Colon C18 23 94.8 0.9 - 0.9 3.5
  Rectum, rectosigmoid C19-20 13 93.8 - 1.6 - 4.7
  Anus C21 1 100.0 - - - -
  Liver C22 4 66.7 - 23.8 - 9.5
  Gallbladder, bile ducts C23-24 4 50.0 5.6 11.1 - 33.3
  Pancreas C25 13 47.6 - 25.4 - 27.0
  Other digestive organs C26 1 - - - - 100.0
Respiratory organs C30-39 17 60.2 16.9 13.3 - 9.6
  Nose, sinuses C30-31 0 50.0 - - - 50.0
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 15 60.0 18.7 14.7 - 6.7
  Mediastinum, pleura C38 0 - - - - 100.0
Bone C40-41 0 50.0 - 50.0 - -
Melanoma of the skin C43 12 100.0 - - - -
Skin, non-melanoma C44 10 98.0 - - - 2.0
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 2 100.0 - - - -
Breast C50 98 98.8 - 0.2 0.2 0.8
Female genital organs C51-58 44 94.1 2.7 1.8 - 1.4
  Cervix uteri C53 3 92.9 - 7.1 - -
  Corpus uteri C54 23 99.1 - - - 0.9
  Uterus, other C55,C58 - - - - - -
  Ovary C56 13 83.6 9.0 4.5 - 3.0
  Other female genital C51-52,C57 5 100.0 - - - -
Urinary organs C64-68 14 89.9 1.4 2.9 1.4 4.3
  Kidney C64 8 92.1 - 5.3 2.6 -
  Bladder and urinary tract2 C65-68 6 87.1 3.2 - - 9.7
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 12 87.9 - 3.4 1.7 6.9
Thyroid gland C73 5 100.0 - - - -
Other endocrine glands C74-75 - - - - - -
Illdefined or unknown C76,C80 10 44.0 16.0 18.0 - 22.0
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 26 75.2 10.1 1.6 - 13.2
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 12 98.3 - - - 1.7
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 4 61.9 14.3 9.5 - 14.3
  Leukaemia C91-95 5 50.0 26.9 - - 23.1
  Myelodysplastic syndromes D46 1 - 28.6 - - 71.4
  Myeloproliferaitive neoplasms D45,D47 2 72.7 9.1 - - 18.2
Not included above
  Carcinoma in situ of the breast D05 6 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 9 100.0 - - - -
  Borderline tumour of the ovary D39 4 100.0 - - - -
  Basal cell carcinoma of the skin 105 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.